Location: Food Components and Health Laboratory2021 Annual Report
Objective 1: Determine the genotype, phenotype and food matrix factors that influence absorption, distribution, metabolism or excretion of glucosinolates, phenolics, and other food components. Objective 2: Determine how consumption of foods and food components, including but not limited to glucosinolates, phenolics, and carotenoids, modulate inflammatory and metabolic pathways that affect risk for cardiovascular diseases, diabetes, cancer, and other chronic disease.
U.S. agriculture provides us with myriad dietary components that can have a significant impact on health. The human diet contains thousands of bioactive food components which have a multitude of physiologic actions, some of which can interrupt processes in the development of a host of chronic diseases. The goal of this project plan is to enhance the understanding of physiologic actions of diet-based bioactive compounds to improve their absorption and efficacy in promoting health and preventing disease. We have organized this project to address current and emerging nutrition issues while capitalizing on the experience and expertise of the research team assigned to this project. We will address the following factors for several different categories of food components and bioactives: how much of a dietary component we absorb from the food, how well we retain and utilize that dietary component, and how the bioactive compounds function in the body (mechanisms of action) to prevent the most significant modifiable health risks faced by American adults, including cardiovascular disease, diabetes, and cancer. Bioactive compounds will include polyphenols, carotenoids, and sulfur compounds from Brassica vegetables, because all demonstrate promising health benefits, and work with these compounds capitalizes on previous progress in our laboratory.
This report is for project 8040-51000-059-00D entitled "Absorption, Distribution, Metabolism, and Excretion of Food Components and their Impact on Chronic Disease Risk." The project contributes to National Program 107 and focuses on Component 1 Linking Agricultural Practices and Beneficial Health Outcomes, Component 3 (Scientific Basis for Dietary Guidance), and Component 4 (Prevention of Obesity and Obesity-Related Diseases) through human studies focusing on Brassica vegetables, whole grains, and berries. For Objective 1, a study of whole grains (oats and wheat) is ongoing to investigate how the processing of grains impacts the absorption, distribution, metabolism, and excretion of phenolics (5-n-alkylresorcinols, avenanthramides, saponins) found in whole grains. The dietary intervention phase has been completed, and lab analysis of samples is continuing. This research will also identify patterns of phenolic circulation and excretion that may further aid in developing biomarkers of intake of whole grains. Assessing the intake of whole grains is increasingly important as their use in the food supply is expanding. Determining the intake of whole grains (through biomarkers) will facilitate a better understanding of their health effects. The absorption, distribution, metabolism, and excretion of vitamin D in pregnant women were studied in collaboration with scientists at Cornell University. During pregnancy, the blood pool of the active form of vitamin D increases throughout most of the pregnancy period. Why or how this phenomenon occurs is unknown, but it likely represents an important adaptation to the growing child's health. A new lab method was developed to measure the amount of the isotopically-labeled vitamin forms in the body. It was found that the women in the study had marked variability in their vitamin D metabolism and that a protein called "vitamin D binding protein" had the greatest influence on the vitamin D metabolism. The new method developed in this work will allow further studies of vitamin D metabolism in various populations, including pregnant and nonpregnant women. A dietary intervention study of chickpeas and lentils was completed better to understand the absorption of macronutrients from these pulses. This research will measure the metabolizable energy value of chickpeas and lentils, which has never been studied in humans. Analyses of samples are ongoing. Already, this research has identified errors in food labels for chickpeas and lentils – showing that food labels overestimate the energy (calories) in these foods. Lab analysis of samples from human dietary intervention studies of brassica vegetables (kale and broccoli) continues. These studies focused on how food preparation methods might alter the absorption, metabolism, and excretion of bioactive glucosinolates from these foods. For Objective 2, analysis of data from a dietary intervention study of berries is continuing. Specifically, investigations at the mitochondrial level are being analyzed to determine how berry and berry components might alter critical energy-metabolism pathways at the cellular level. This research focuses on how these changes in metabolism might explain some of the bodyweight-related changes that have been observed following berry consumption.
Shinn, L.M., Li, Y., Mansharamani, A., Zhu, R., Auvil, L., Welge, M., Bushell, C., Khan, N.A., Charron, C.S., Novotny Dura, J., Baer, D.J., Holscher, H.D. 2020. Fecal bacteria as biomarkers for predicting food intake in healthy adults. Journal of Nutrition. https://doi.org/10.1093/jn/nxaa285.
Sun, J., Charron, C.S., Zhihao, L., Novotny Dura, J., Harrington, P.B., Ross, S.A., Seifried, H.E., Chen, P. 2020. Study on human urinary metabolic profiles after consumption of kale and daikon radish using high-resolution mass spectrometry-based non-targeted and targeted metabolomic approach. Journal of Agricultural and Food Chemistry. 68:14307-14318. https://doi.org/10.1021/acs.jafc.0c05184.
Charron, C.S., Vinyard, B.T., Jeffery, E., Ross, S., Seifried, H., Novotny, J.A. 2020. BMI is associated with increased plasma and urine appearance of glucosinolate metabolites after consumption of cooked broccoli. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2020.575092.